Adults ages 55-74 needed for pneumonia vaccine study
Researchers with the Vanderbilt Vaccine Research Program are looking for adults between the ages of 55 and 74 to participate in a research study involving a pneumonia vaccine.
Participation in this study requires three clinic visits over six months. Participants will be compensated for their time and travel.
For more information or to see if you qualify, email email@example.com or call 322-2730.